• Estimation of the Effects and Costs of Lifestyle Intervention and Treatment With Voglibose in the Japanese Prediabetic Population: A Cost-Effectiveness Analysis

    May 1, 2025, 00:00
  • Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Among Adults in the Philippines

    May 1, 2025, 00:00
  • Cost Analysis of Epilepsy Healthcare in Adults: A Direct Cost Estimate From a Colombian Perspective

    May 1, 2025, 00:00
  • Cost-Effectiveness of Mineralocorticoid Receptor Antagonists in Ischemic and Nonischemic Heart Failure With Reduced Ejection Fraction: Perspective From a Universal Healthcare System

    May 1, 2025, 00:00
  • Valuing an Index of Sanitation-Related Quality of Life in Urban Mozambique: A Discrete Choice Experiment

    May 1, 2025, 00:00
  • Life With Cystic Fibrosis: The Socioeconomic Impact on Patients and Their Caregivers

    May 1, 2025, 00:00
  • Quality of Life of Older Adults Living With Dementia and Caregiver Strain in Benin

    May 1, 2025, 00:00
  • Comparing the Measurement Properties of the Preliminary Version of the EuroQol Health and Well-Being and EQ-5D-5L in Patients, Healthy General Public, and Caregivers

    May 1, 2025, 00:00
  • Cost-Effectiveness Analysis of Pharmacological Treatment With Insulin and Insulin Analogs for Type 1 and Type 2 Diabetes Mellitus in Colombia

    May 1, 2025, 00:00
  • Toward Better Measurement of Financial Risk Protection in Health Expenditure: The Case of Chile

    May 1, 2025, 00:00
  • Patient-Reported Experience and Outcome Measures of Patients Living With Diabetes: Associations Among Different Factors

    May 1, 2025, 00:00
  • Cost-Effectiveness Analysis of Inclisiran for the Treatment of Primary Hypercholesterolemia or Mixed Dyslipidemia in Singapore

    May 1, 2025, 00:00
  • Editorial Board

    May 1, 2025, 00:00
  • Economic and Disease Burden of Multiple Sclerosis in Colombia

    May 1, 2025, 00:00
  • Table of Contents

    May 1, 2025, 00:00
  • Matching-Adjusted Indirect Comparison Studies in Oncology: A Scoping Review Focused on Reporting Quality

    May 1, 2025, 00:00
  • Reviewer Acknowledgment

    Apr 30, 2025, 10:29
  • Table of Contents

    Mar 17, 2025, 11:40
  • Cost-Utility Analysis of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy Regimen in Comparison With Gemcitabine and Cisplatin Chemotherapy Regimen in the Treatment of Patients With Muscle Invasive Bladder Cance ...

    Mar 1, 2025, 00:00
  • Effects of Reimbursement Add-On Policies on Trastuzumab and Bevacizumab Biosimilar Adoption in a Japanese Oncology Setting

    Mar 1, 2025, 00:00
  • Healthcare Costs and Early Complications in Liver-Transplanted Patients With Portal Vein Thrombosis: Experience From a Colombian Reference Center

    Mar 1, 2025, 00:00
  • Health-Related Quality of Life in a Slovak Representative Sample: A Validation Study of the Short Form-8 Scale

    Mar 1, 2025, 00:00
  • Cost-Effectiveness Analysis of Idursulfase for the Long-Term Treatment of Hunter Syndrome Using a Partitioned-Survival Model Approach in R

    Mar 1, 2025, 00:00
  • Utility Values of Health Status in Gastric Cancer: A Systematic Review

    Mar 1, 2025, 00:00
  • Efficiency Analysis of Healthcare Systems in Latin American and Caribbean Countries: An Application Based on Data Envelopment Analysis

    Mar 1, 2025, 00:00
  • Cost-Effectiveness of Aerial Logistics for Immunization: A Model-Based Evaluation of Centralized Storage and Drone Delivery of Vaccines in Ghana Using Empirical Data

    Mar 1, 2025, 00:00
  • The High Cost of the Legal Route in Public Health: The Impact of the Judicialization of Medicines in the Municipal Unified Health System in Campinas

    Mar 1, 2025, 00:00
  • Exploring the Potential Health and Economic Benefits of Optimized Low-Density Lipoprotein Cholesterol Management in Malaysia’s Atherosclerotic Cardiovascular Disease Population: A Model-Based Analysis

    Mar 1, 2025, 00:00
  • Rare Oncological Diseases and Their Large Slice in Demands to the Brazilian Government for Health Technologies Over 12 Years Since the Creation of CONITEC

    Mar 1, 2025, 00:00
  • Using Real-World Evidence for Health Technology Assessment in Asia: Suggested Typology and Scoping Review

    Mar 1, 2025, 00:00
  • Cost-Effectiveness Analysis of Upadacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in Greece

    Mar 1, 2025, 00:00
  • Glycemic and Blood Pressure Control in Type 2 Diabetes Mellitus: Disability Costs Covered by Social Security, Evidence From Mexico

    Mar 1, 2025, 00:00
  • Budget Impact Analysis of Intravitreal Injections Used to Treat Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in the Dubai Healthcare System

    Mar 1, 2025, 00:00
  • Understanding What Matters: Stakeholder Views on Decision Criteria for Cancer Drug Selection in the Public Sector in Malaysia

    Mar 1, 2025, 00:00
  • Editorial Board

    Mar 1, 2025, 00:00
  • Population Norms and Disutility Catalog for Chronic Conditions in Sri Lanka

    Jan 1, 2025, 00:00
  • The Burden of Alzheimer’s Disease and Its Costs to a Healthcare System in a Large Population in Brazil

    Jan 1, 2025, 00:00
  • Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment

    Jan 1, 2025, 00:00
  • The Reform Dynamics of State Management Practices in the Healthcare Sector of the Republic of Kazakhstan: A Global and Local Perspective

    Jan 1, 2025, 00:00
  • Economic Burden of Sickle Cell Disease in Saudi Arabia

    Jan 1, 2025, 00:00
  • Main Predictors of Decreasing in Quality of Life in Patients With Post-COVID-19: A Cross-Sectional Study

    Jan 1, 2025, 00:00
  • An EQ-5D-5L Value Set for Ghana Using an Adapted EuroQol Valuation Technology Protocol

    Jan 1, 2025, 00:00
  • Savings Through Telemedicine: Initial Data From a Hospital-at-Home Program

    Jan 1, 2025, 00:00
  • Postpartum Screening for Type 2 Diabetes in Women With a History of Gestational Diabetes Mellitus: A Cost-Effectiveness Analysis in Singapore

    Jan 1, 2025, 00:00
  • Chronic Pain—A Global Problem Demanding Local Evidence and Guidelines

    Jan 1, 2025, 00:00
  • Psychometric Evaluation of the Bengali Short Form 12 Version 2 Health Survey in Patients With Inflammatory Bowel Disease

    Jan 1, 2025, 00:00
  • Editorial Board

    Jan 1, 2025, 00:00
  • Health Services Costs of Clinical Heart Failure With Reduced Ejection Fraction in Singapore

    Jan 1, 2025, 00:00
  • Table of Contents

    Jan 1, 2025, 00:00
  • The Use of a Specialized Oral Nutritional Supplement in the Management of Chronic Wounds in Patients With and Without Diabetes Mellitus: Cost-Effectiveness Analysis

    Jan 1, 2025, 00:00
  • Editorial Board

    Nov 1, 2024, 08:25
  • Retraction notice to Cost-effectiveness of the Recombinant Zoster Vaccine among People Living with Human Immunodeficiency Virus in Japan

    Nov 1, 2024, 00:00
  • Analysis of Factors Influencing Hospitalization Expenses of Patients With Gastric Cancer in Shanghai, 2014-2021: Based on Grey Relational Analysis and Structural Equation Modeling [Editor's Choice]

    Nov 1, 2024, 00:00
  • Table of Contents

    Nov 1, 2024, 00:00
  • Custo Direto do Tratamento do Acidente Vascular Cerebral Isquêmico na Perspectiva de um Hospital Público Terciário (Direct Cost of Treating Ischemic Stroke From the Perspective of a Tertiary Public Hospital)

    Nov 1, 2024, 00:00
  • Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3

    Nov 1, 2024, 00:00
  • Health-Related Quality of Life in Chronic Pain Treated With Tapentadol Versus Oxycodone/Naloxone and Its Determinants: A Real-World, Single-Center Retrospective Cohort Study in Spain

    Nov 1, 2024, 00:00
  • Assessing the Impact of a Designated Pharmacist Intervention on Drug Treatment Costs and Technical Efficiency in the Hemato-Oncology Outpatient Clinic [Editor's Choice]

    Nov 1, 2024, 00:00
  • Custo-Efetividade de Diferentes Tratamentos Minimamente Invasivos Para Disfunção Temporomandibular de Origem Articular sob a Perspectiva do Sistema Público de Saúde Brasileiro

    Nov 1, 2024, 00:00
  • Treatment Cost and Psychological Impact of Burkitt Lymphoma on Ghanaian Families and Caregivers

    Nov 1, 2024, 00:00
  • Health-Related Quality of Life and Economic Analysis of Olanzapine Versus Aprepitant in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy in Malaysia

    Nov 1, 2024, 00:00
  • The 30-Billion-Dollar Distribution Markups and Taxes of Pharmaceuticals in Latin American Countries: Impact, Options, and Trade-Offs [Editor's Choice]

    Nov 1, 2024, 00:00
  • Patient Experience of Herpes Zoster Disease in Argentina: Validation of a Health-Related Quality of Life Conceptual Model

    Nov 1, 2024, 00:00
  • Cost-Effectiveness of Dolutegravir Compared With Efavirenz for Prevention of Perinatal Transmission in Women Presenting With HIV in Late Pregnancy in Uganda

    Nov 1, 2024, 00:00
  • Changes in Health Spending During the COVID-19 Pandemic by Expenditure Type and Household Profiles in Mexican Households [Editor's Choice]

    Nov 1, 2024, 00:00
  • Cost-effectiveness of the Recombinant Zoster Vaccine Among People Living with Human Immunodeficiency Virus in Japan [VHRI Volume 44, November 2024, 101025]

    Nov 1, 2024, 00:00
  • Psychometric Measurements of the Adherence to Refills and Medication Scales Among Patients With HIV/AIDS in Indonesia

    Nov 1, 2024, 00:00
  • Societal Preferences in Health Technology Assessments for Rare Diseases and Orphan Drugs: A Systematic Literature Review of New Analytic Approaches

    Nov 1, 2024, 00:00
  • Microcosting Analysis of Advanced Ovarian Cancer: Real-World Evidence From the Perspective of a Reference Public Brazilian Hospital

    Sep 1, 2024, 00:00
  • Challenges and Reflections on Pandemic Disinformation: The Case of Hydroxychloroquine and the Implications for Global Public Health

    Sep 1, 2024, 00:00
  • Simplified Chronic Hepatitis B Antiviral Initiation Criteria in Thailand: An Economic Evaluation

    Sep 1, 2024, 00:00
  • Lenalidomide or Thalidomide for Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma? An Overview of Systematic Reviews

    Sep 1, 2024, 00:00
  • The Impact of Generic Entry of Pharmaceuticals in Australia [Editor's Choice]

    Sep 1, 2024, 00:00
  • Cost-Effectiveness of Increasing Access to Colorectal Cancer Diagnosis: Analysis From Thailand

    Sep 1, 2024, 00:00
  • Societal Preferences for Subsidizing Treatments Targeting Patients With Advanced Illness: A Discrete Choice Experiment [Editor's Choice]

    Sep 1, 2024, 00:00
  • Hospital Healthcare Resource Utilization and Associated Hospital Costs of Patients With Lupus Nephritis in China: A National Administrative Claim Database Study

    Sep 1, 2024, 00:00
  • The Impact of COVID-19 on Healthcare Utilization in Turkey

    Sep 1, 2024, 00:00
  • Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non–Small Cell Lung Cancer in Jordan

    Sep 1, 2024, 00:00
  • Epidemiology, Treatment Patterns, and Healthcare Resource Utilization Study of Patients With Alopecia Areata in Taiwan’s National Health Insurance Research Database

    Sep 1, 2024, 00:00
  • Editorial Board

    Sep 1, 2024, 00:00
  • Patient Preferences for Out-of-Hospital Cardiac Arrest Care in South Africa: A Discrete Choice Experiment

    Sep 1, 2024, 00:00
  • Incremental Healthcare Costs of Diabetes Mellitus in a Middle-Income Country Using Administrative Healthcare Data [Editor's Choice]

    Sep 1, 2024, 00:00
  • Evaluation of the Concept of Value-Based Healthcare Applied to an Integrated Palliative Care Program in Colombia [Editor's Choice]

    Sep 1, 2024, 00:00
  • Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran [Editor's Choice]

    Sep 1, 2024, 00:00
  • Consensus-Based Recommendations for the Implementation of Health Technology Assessment in the United Arab Emirates

    Sep 1, 2024, 00:00
  • Table of Contents

    Aug 27, 2024, 14:16
  • Cost-Effectiveness of Technologies for the Treatment of Spinal Muscular Atrophy: A Systematic Review of Economic Studies [Editor's Choice]

    Jul 1, 2024, 00:00
  • Editorial Board

    Jul 1, 2024, 00:00
  • Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature

    Jul 1, 2024, 00:00
  • Cost-Effectiveness of Ibrutinib for Chronic Lymphocytic Leukemia Treatment in India: Is Evidence Really at Crossroads?

    Jul 1, 2024, 00:00
  • Examining the Impact of the Current Reimbursement Regulation on Patient Access to Innovative Medical Devices in Taiwan: Insights From 8 Years’ Reimbursement Data [Editor's Choice]

    Jul 1, 2024, 00:00
  • The Process of Listing Prostheses and Medical Devices in Thailand’s Universal Health Coverage [Editor's Choice]

    Jul 1, 2024, 00:00
  • Quality of Life in Transfusion-Dependent Thalassemia Patients in Greece Before and During the COVID-19 Pandemic

    Jul 1, 2024, 00:00
  • Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region

    Jul 1, 2024, 00:00
  • Cost-Effectiveness Analysis of Pharmacological Treatment for Adult Kidney Transplant Recipients in Colombia [Editor's Choice]

    Jul 1, 2024, 00:00
  • Table of Contents

    Jul 1, 2024, 00:00
  • Electronic Decision-Making Tool for Smoking Cessation (Pare de Fumar Conosco) Versus Standard of Care: A Cost-Effectiveness Analysis

    Jul 1, 2024, 00:00
  • A Microcost Analysis of the Use of Personal Protective Equipment During and Before the COVID-19 Pandemic From a Hospital Perspective

    Jul 1, 2024, 00:00
  • Estimating the SF-6Dv1 Value Set for a Population-Based Sample in Lebanon [Editor's Choice]

    Jul 1, 2024, 00:00
  • Mortalidad, Secuelas Clínicas y Calidad de Vida Luego del Alta de Unidades de Cuidados Intensivos en Pacientes con COVID-19: Estudio Multicéntrico Descriptivo en Argentina

    Jul 1, 2024, 00:00
  • Partial-Cost Analysis and Economic Impact of Ambulatory Coronary Angioplasty in a Private Hospital in the Caribbean

    Jul 1, 2024, 00:00
  • Cost-Effectiveness Analysis of Triptorelin, Goserelin, and Leuprolide in the Treatment of Patients With Metastatic Prostate Cancer: A Societal Perspective

    Jul 1, 2024, 00:00
  • Cost-Effectiveness Analysis of Implant-Supported Single Crown and Tooth-Supported Fixed Dental Prostheses in Türkiye

    Jul 1, 2024, 00:00
  • Table of Contents

    May 7, 2024, 17:27
  • Estimating the Costs of End-of-Life Care in Patients With Advanced Cancer From the Perspective of an Insurance Organization: A Cross-Sectional Study in Iran

    May 1, 2024, 00:00
  • Impact of Lung Cancer on Health-Related Quality of Life, Financial Toxicity, and Household Economics in Patients From the Public and the Private Healthcare Sector in Argentina [Editor's Choice]

    May 1, 2024, 00:00
  • A Step Toward the Development of the First National Multi-Criteria Decision Analysis Framework to Support Healthcare Decision Making in Saudi Arabia [Editor's Choice]

    May 1, 2024, 00:00
  • Assessment of Extent and Quality of Pharmacoeconomic Studies in India Using Quality of Health Economic Studies Score: A Targeted Literature Review

    May 1, 2024, 00:00
  • Analysis of Health-Related Quality of Life and Incurred Costs Among Human Immunodeficiency Virus, Tuberculosis, and Tuberculosis/HIV Coinfected Outpatients in Indonesia

    May 1, 2024, 00:00
  • The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand [Editor's Choice]

    May 1, 2024, 00:00
  • Quality of Life of Patients With Cancer at the Beni Mellal Oncology Center

    May 1, 2024, 00:00
  • Financial Toxicity Experiences of Patients With Cancer in Indonesia: An Interpretive Phenomenological Analysis

    May 1, 2024, 00:00
  • Portuguese Global Medicines Access Index 2021: An Indicator to Measure Access to Hospital Medicines

    May 1, 2024, 00:00
  • Economic Evaluation of Neoadjuvant Versus Adjuvant Chemotherapy in Cancer Treatment: A Systematic Review and Meta-Analysis

    May 1, 2024, 00:00
  • Peripherally Inserted Central Catheter Versus Centrally Inserted Central Catheter for In-Hospital Infusion Therapy: A Cost-Effectiveness Analysis

    May 1, 2024, 00:00
  • Psychometric Properties of the Persian Dizziness Handicap Inventory – Screening Version

    May 1, 2024, 00:00
  • Editorial Board

    May 1, 2024, 00:00
  • Service Utilization Patterns and Direct Medical Costs of Hospitalization in Patients With Renal Failure Before and After Initiating Home Peritoneal Dialysis

    May 1, 2024, 00:00
  • The Short-Term Cost-Effectiveness of a Fixed-Ratio Combination of Insulin Degludec and Aspart: A Cost of Control Analysis in Australia and India

    May 1, 2024, 00:00
  • The Shortfalls of Mental Health Compartment Models: A Call to Improve Mental Health Investment Cases in Developing Countries [Editor's Choice]

    May 1, 2024, 00:00
  • Cost-Effectiveness Analysis Comparing QuantiFERON-TB Gold Plus Test and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Immunocompetent Subjects in Colombia

    May 1, 2024, 00:00
  • Association of Healthcare Fragmentation and the Survival of Patients With Colorectal Cancer in Colombia [Editor's Choice]

    May 1, 2024, 00:00
  • Automated Peritoneal Dialysis With Remote Patient Monitoring: Clinical Effects and Economic Consequences for Poland

    Mar 1, 2024, 00:00
  • Cost-Effectiveness of Onasemnogene Abeparvovec Compared With Nusinersen and Risdiplam in Patients With Spinal Muscular Atrophy Type 1 in Brazil

    Mar 1, 2024, 00:00
  • Editorial Board

    Mar 1, 2024, 00:00
  • Exploring the Evolution of Statin Pricing in Australia: Observations of Price Disclosure Effects on Pharmaceutical Benefits Scheme Expenditure

    Mar 1, 2024, 00:00
  • Costs of Receiving Developmental Services for Children With Global Developmental Delay at Siriraj Hospital in Bangkok, Thailand

    Mar 1, 2024, 00:00
  • Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan

    Mar 1, 2024, 00:00
  • A Vulnerability Index for Mitigation and Prevention of Diabetes Growth in India: A Disaggregated Analysis [Editor's Choice]

    Mar 1, 2024, 00:00
  • Determining the Willingness to Pay for Innovative Oncology Medicines in Malaysia [Editor's Choice]

    Mar 1, 2024, 00:00
  • Cost-Utility Analysis of Continuous Positive Airway Pressure Therapy Compared With Usual Care for Obstructive Sleep Apnea in the Public Health System in Brazil

    Mar 1, 2024, 00:00
  • The Urban-Rural Difference in Child Mental Health in Vietnam: The Continuing Impacts of the COVID-19 Pandemic on Health

    Mar 1, 2024, 00:00
  • Cost-Utility Model of Nirmatrelvir/Ritonavir in Brazil: Analysis of a Vaccinated Population [Editor's Choice]

    Mar 1, 2024, 00:00
  • The Economic Burden of Biological Drugs in Rheumatoid Arthritis Treatment [Editor's Choice]

    Mar 1, 2024, 00:00
  • Multivariate Relationships Between Health Outcomes and Health System Performance Indicators: An Integrated Factor Analysis With Canonical Correlations [Editor's Choice]

    Mar 1, 2024, 00:00
  • Economic Burden of Alzheimer’s Disease: A Systematic Review

    Mar 1, 2024, 00:00
  • Evolving Trends and Economic Burden of Benzodiazepine Use: Insights From a 10-Year Predictive Model

    Mar 1, 2024, 00:00
  • Comparative Analysis of the Healthcare Delivery System in China and Nigeria: A Review

    Mar 1, 2024, 00:00
  • Table of Contents

    Feb 26, 2024, 08:36
  • Copyright/Subscription

    Jan 12, 2024, 10:29
  • Study of the Direct Costs of Asthma at a Healthcare Service Provider in Bogotá, Colombia

    Jan 1, 2024, 00:00
  • Research-to-Policy Partnerships for Evidence-Informed Resource Allocation in Health Systems in Africa: An Example Using the Thanzi Programme

    Jan 1, 2024, 00:00
  • Revision of Malawi’s Health Benefits Package: A Critical Analysis of Policy Formulation and Implementation [Editor's Choice]

    Jan 1, 2024, 00:00
  • Editorial Board

    Jan 1, 2024, 00:00
  • Estimation of Societal Values of Health States Preferences at the National Level for Low- and Middle-Income Countries [Editor's Choice]

    Jan 1, 2024, 00:00
  • Adapting Economic Evaluation Methods to Shifting Global Health Priorities: Assessing the Value of Health System Inputs [Editor's Choice]

    Jan 1, 2024, 00:00
  • Table of Contents

    Jan 1, 2024, 00:00
  • Breast Cancer Screening in Georgia: Choosing the Most Optimal and Cost-Effective Strategy

    Jan 1, 2024, 00:00
  • Choosing the Best Instrument for Measuring Health Spillover Effect in Caregivers of Patients With Multiple Sclerosis [Editor's Choice]

    Jan 1, 2024, 00:00
  • Scoping Review of Health Economics Research on Refugee Health in Sub-Saharan Africa

    Jan 1, 2024, 00:00
  • Central America and the Dominican Republic at Crossroads: The Importance of Regional Cooperation and Health Economic Research to Address Current Health Challenges

    Jan 1, 2024, 00:00
  • Cost-Effectiveness of Comprehensive Genomic Profiling in Patients With Non–Small Cell Lung Cancer for the Colombian Health System [Editor's Choice]

    Jan 1, 2024, 00:00
  • The Checklist for Standard Methodological Requirements and Reporting of Economic Evaluation of Medicines in Slovakia

    Jan 1, 2024, 00:00
  • Forging Partnership Between Health Economics Researchers and Policy Makers: Better Methods, Better Policy, Better Health

    Jan 1, 2024, 00:00
  • Economical Evaluation of Prostate Cancer Treatment Using Intensity-Modulated Radiation Therapy, 3-Dimensional Conformal Radiation Therapy and Radical Prostatectomy: A Systematic Review

    Jan 1, 2024, 00:00
  • Decision-Utility Analysis of Empiric Treatment Versus Test and Treat Strategies for Helicobacter pylori in Patients With Duodenal Ulcer

    Jan 1, 2024, 00:00
  • Looking to the Future: A Vision for Value in Health Regional Issues

    Jan 1, 2024, 00:00
  • Health System Financing and Resource Allocation in Humanitarian Settings: Toward a Collaborative Policy Research Agenda in the Eastern Mediterranean Region

    Jan 1, 2024, 00:00
  • Demands for Intersectoral Actions to Meet Health Challenges in East and Southern Africa and Methods for Their Evaluation

    Jan 1, 2024, 00:00
  • Copyright/Subscription

    Nov 13, 2023, 10:52
  • Should the Preference-Based Index Set of Values Be Country or Disease Specific? An Analysis Using Data From Women With Symptoms of Overactive Bladder

    Nov 1, 2023, 00:00
  • Cost-Effectiveness of Hospice Palliative Care for Patients With Cancer and Family Caregivers: A Multicenter Study in Kazakhstan

    Nov 1, 2023, 00:00
  • Integrating Noncancer Chronic Pain to Multimorbidity: A Real Practice Challenge in Chile

    Nov 1, 2023, 00:00
  • Willingness to Pay for Colorectal Cancer Screening in Vietnam: Policy Implications From a Contingent Valuation Survey [Editor's Choice]

    Nov 1, 2023, 00:00
  • Early Cost-Utility Analysis of Ataluren and Eteplirsen in the Treatment of Duchenne Muscular Dystrophy in Egypt

    Nov 1, 2023, 00:00
  • Table of Contents

    Nov 1, 2023, 00:00
  • The Relationship Between the Health Transformation Program and Health Expenditures: Evidence From an Autoregressive Distributed Lag Testing Approach

    Nov 1, 2023, 00:00
  • Trajectories of Cancer Care in Latin America: A Scope Review

    Nov 1, 2023, 00:00
  • Home Gardening of Yellow Cassava and Orange Maize for the Prevention of Nutritional Blindness in Children: An Economic Evaluation and Value of Information Analysis

    Nov 1, 2023, 00:00
  • Critical Analysis of Economic Evaluation of the Childhood Rotavirus Vaccination in Low- and Lower-Middle-Income Countries: A Systematic Review

    Nov 1, 2023, 00:00
  • Cost-Effectiveness of Osteoporosis Opportunistic Screening Using Computed Tomography in China [Editor's Choice]

    Nov 1, 2023, 00:00
  • Cost-Effectiveness of Ibrutinib as First-line Treatment for Older Patients With Chronic Lymphocytic Leukemia in Iran

    Nov 1, 2023, 00:00
  • Editorial Board

    Nov 1, 2023, 00:00
  • Cost-Effectiveness of Tacrolimus Compared With Cyclosporine for Immunosuppression Therapy in Patients Who Underwent Heart Transplant in Colombia

    Nov 1, 2023, 00:00
  • Evaluation of a Transitional Care Strategy Implemented in Adults With High-Risk and Multimorbidity in Chile

    Nov 1, 2023, 00:00
  • The Cost-Effectiveness of Pertuzumab for the Treatment of Metastatic HER2+ Breast Cancer in Czechia: A Semi-Markov Model Using Cost States

    Nov 1, 2023, 00:00
  • Cost-Effectiveness of Glucose-Lowering Therapies as Add-on to Standard Care for People With Type 2 Diabetes in Malaysia [Editor's Choice]

    Nov 1, 2023, 00:00
  • Factors Affecting Inequality in the Quality Diets: A Scoping Review

    Sep 1, 2023, 00:00
  • Real-World Costs and Cost-Effectiveness Analysis of Rabbit-Antithymocyte Globulin Versus Oxymetholone in Acquired Aplastic Anemia in Thailand

    Sep 1, 2023, 00:00
  • Burden of COVID-19 in Córdoba, A Department of Colombia: Results of Disability-Adjusted Life-Years

    Sep 1, 2023, 00:00
  • Exploring the COVID-19 Pandemic’s Impact on the Health Technology Assessment Process of the National Commission for the Incorporation of Technologies Into the Brazilian Health System [Editor's Choice]

    Sep 1, 2023, 00:00
  • The Disease Burden and Economic Burden of Cancer in 9 Countries in the Middle East and Africa [Editor's Choice]

    Sep 1, 2023, 00:00
  • The Triglycerides and Glucose Index: A Cost-Effectiveness Analysis Compared With the Homeostatic Model Assessment for Insulin Resistance

    Sep 1, 2023, 00:00
  • Editorial Board

    Sep 1, 2023, 00:00
  • Eficácia E Custo-Utilidade De Intervenções Para O Tratamento Da Enurese Em Crianças E Adolescentes Sob A Perspectiva Do Sistema Único De Saúde Brasileiro

    Sep 1, 2023, 00:00
  • Cost-Effectiveness Analysis of Relmacabtagene Autoleucel for Relapsed or Refractory Large B-Cell Lymphoma in China

    Sep 1, 2023, 00:00
  • Sensitivity Analysis in Economic Evaluations of Immuno-Oncology Drugs: A Systematic Literature Review

    Sep 1, 2023, 00:00
  • Healthcare Costs and Utilization for Patients With Systemic Lupus Erythematosus in China: A National Claims Database Study [Editor's Choice]

    Sep 1, 2023, 00:00
  • Prioritizing Outcome Measures for Value-Based Healthcare: Physicians’ Perspectives in Saudi Arabia

    Sep 1, 2023, 00:00
  • Cost-Effectiveness Analysis of Monoclonal Antibodies Associated With Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer

    Sep 1, 2023, 00:00
  • The Budget Impact Analysis of Adopting Direct Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation Patients in Malawi

    Sep 1, 2023, 00:00
  • Upfront DPYD Genotype-Guided Treatment for Fluoropyrimidine-Based Chemotherapy in Advanced and Metastatic Colorectal Cancer: A Cost-Effectiveness Analysis

    Sep 1, 2023, 00:00
  • Table of Contents

    Sep 1, 2023, 00:00
  • Assessment of Health-Related Quality of Life Using EQ-5D-5L Tool With Indian Tariffs Among Reproductive Age Group Women Living With HIV in India [Editor's Choice]

    Sep 1, 2023, 00:00
  • Instructions for Authors

    Sep 1, 2023, 00:00
  • Copyright/Subscription

    Aug 25, 2023, 08:58
  • Reimbursement Coverage Decision Making for Digital Health Technologies in South Korea: Does It Fit the Value Framework Used in Traditional Medical Technologies? [Editor's Choice]

    Jul 1, 2023, 00:00
  • Cost-Effectiveness Analysis of Rituximab for Chronic Lymphocytic Leukemia Using a Semi-Markovian Model Approach in R

    Jul 1, 2023, 00:00
  • Does a Standard Cost-Effectiveness Threshold Exist? The Case of Greece [Editor's choice]

    Jul 1, 2023, 00:00
  • Table of Contents

    Jul 1, 2023, 00:00
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »